Leonard Braden Michael

Talis Biomedical Corporation · 10% Owner

Leonard Braden Michael is listed in filings as 10% Owner at Talis Biomedical Corporation. This profile follows SEC Form 4 activity through May 18, 2026, including purchase activity and sale activity. Recent filings connect the profile to Talis Biomedical Corporation (TLIS), Tectonic Therapeutic, Inc. (TECX), Outset Medical, Inc. (OM), and OnKure Therapeutics, Inc. (OKUR). The current snapshot covers public activity from Jun 13, 2024 to May 18, 2026. Reported amounts are shown as $51.3K to $642. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Talis Biomedical CorporationTLIS$51k13.2k sharesBuyAug 26, 2024$3.90$2.84
Talis Biomedical CorporationTLIS$4.8k1.2k sharesBuyAug 28, 2024$3.96$2.84
Talis Biomedical CorporationTLIS$642151 sharesBuyAug 30, 2024$4.25$2.84
Talis Biomedical CorporationTLIS$2k500 sharesBuySep 3, 2024$4.00$2.84
Talis Biomedical CorporationTLIS$7.1k5.1k sharesBuySep 5, 2024$1.40$2.84
Talis Biomedical CorporationTLIS$37k25k sharesBuySep 6, 2024$1.48$2.84
Astrotech CorporationASTC$53k9.2k sharesSellOct 3, 2025$5.83$7.73
Astrotech CorporationASTC$2M220.4k sharesSellOct 3, 2025$7.13$7.73
AN2 Therapeutics, Inc.ANTX$2M1.5M sharesBuyAug 14, 2024$1.04$4.68
AN2 Therapeutics, Inc.ANTX$7.2k7k sharesSellMay 30, 2025$1.03$4.68
AN2 Therapeutics, Inc.ANTX$429k425k sharesSellMay 30, 2025$1.01$4.68
AN2 Therapeutics, Inc.ANTX$116k100k sharesSellMay 28, 2025$1.16$4.68
AN2 Therapeutics, Inc.ANTX$2M2M sharesSellMay 28, 2025$1.16$4.68
AN2 Therapeutics, Inc.ANTX$218k200k sharesSellMay 28, 2025$1.09$4.68
Adverum Biotechnologies, Inc.ADVM$1M135.5k sharesBuyJul 17, 2024$7.75$4.36
Adverum Biotechnologies, Inc.ADVM$736k80.7k sharesBuyJul 18, 2024$9.11$4.36
Adverum Biotechnologies, Inc.ADVM$613k85.8k sharesBuyJul 30, 2024$7.15$4.36
Adverum Biotechnologies, Inc.ADVM$661k164.9k sharesBuyFeb 26, 2025$4.01$4.36
Adverum Biotechnologies, Inc.ADVM$387k86.8k sharesBuyFeb 27, 2025$4.46$4.36
Adverum Biotechnologies, Inc.ADVM$391k85.1k sharesBuyFeb 28, 2025$4.60$4.36
Adverum Biotechnologies, Inc.ADVM$83k18k sharesBuyMar 18, 2025$4.60$4.36
Adverum Biotechnologies, Inc.ADVM$210k44.3k sharesBuyMar 18, 2025$4.73$4.36
Adverum Biotechnologies, Inc.ADVM$123k25k sharesBuyMar 19, 2025$4.94$4.36
Adverum Biotechnologies, Inc.ADVM$172k30.6k sharesBuyMar 20, 2025$5.61$4.36
Adverum Biotechnologies, Inc.ADVM$103k20.4k sharesBuyMar 26, 2025$5.04$4.36
Adverum Biotechnologies, Inc.ADVM$86k16.6k sharesBuyMar 27, 2025$5.19$4.36
Adverum Biotechnologies, Inc.ADVM$86k19.6k sharesBuyMar 31, 2025$4.38$4.36
Adverum Biotechnologies, Inc.ADVM$61k15.2k sharesBuyApr 2, 2025$4.04$4.36
Adverum Biotechnologies, Inc.ADVM$149k50k sharesBuyApr 23, 2025$2.98$4.36
Adverum Biotechnologies, Inc.ADVM$900k300k sharesBuyApr 22, 2025$3.00$4.36
Adverum Biotechnologies, Inc.ADVM$86k16.6k sharesBuyMar 27, 2025$5.19$4.36
Adverum Biotechnologies, Inc.ADVM$930k222.9k sharesSellDec 3, 2025$4.17$4.36
Adverum Biotechnologies, Inc.ADVM$218k52k sharesSellDec 2, 2025$4.20$4.36
Adverum Biotechnologies, Inc.ADVM$1M300k sharesSellDec 1, 2025$4.20$4.36
Adverum Biotechnologies, Inc.ADVM$2M524.6k sharesSellDec 4, 2025$4.19$4.36
Aclaris Therapeutics, Inc.ACRS$1M1M sharesBuyJun 11, 2024$1.08$5.62
Aclaris Therapeutics, Inc.ACRS$94k82.6k sharesBuyJun 12, 2024$1.14$5.62
Aclaris Therapeutics, Inc.ACRS$33k28.6k sharesBuyJun 13, 2024$1.14$5.62
Aclaris Therapeutics, Inc.ACRS$575k500k sharesBuyJun 13, 2024$1.15$5.62
Aclaris Therapeutics, Inc.ACRS$402k345k sharesBuyJun 14, 2024$1.17$5.62
Aclaris Therapeutics, Inc.ACRS$169k150k sharesBuyJun 17, 2024$1.13$5.62
Aclaris Therapeutics, Inc.ACRS$57k50k sharesBuyJun 18, 2024$1.13$5.62
Aclaris Therapeutics, Inc.ACRS$271k235k sharesBuyJun 27, 2024$1.15$5.62
Aclaris Therapeutics, Inc.ACRS$897k801k sharesBuyJun 28, 2024$1.12$5.62
Aclaris Therapeutics, Inc.ACRS$452k400k sharesBuyJun 28, 2024$1.13$5.62
Aclaris Therapeutics, Inc.ACRS$122k107.4k sharesBuyJul 1, 2024$1.14$5.62
Aclaris Therapeutics, Inc.ACRS$98k86.1k sharesBuyJul 2, 2024$1.14$5.62
Aclaris Therapeutics, Inc.ACRS$166k143.3k sharesBuyJul 3, 2024$1.16$5.62
Aclaris Therapeutics, Inc.ACRS$141k123k sharesBuyJul 5, 2024$1.15$5.62
Aclaris Therapeutics, Inc.ACRS$170k130.3k sharesBuyJul 18, 2024$1.30$5.62
Showing 1-50 of 56